Investment Strategy

The Fund's Strategy

• Investing in projects focused on the Russian market with the potential for commercialization in the global market.
• Investing in pre-seed and seed projects/companies, capitalizing investments in an efficient way.
• Investing in projects containing intellectual property that creates natural barriers to competition.
• Funds are only invested in pre-seed and seed companies (RUB 15 mln. per company maximum).

Priority is given to young companies operating in the following areas of life sciences:

• Pharmaceutical technology,
• Cell technology,
• Genomic technology,
• Agrobiotechnology,
• Neurotechnology,
• Bioengineering,
• Medical Equipment,
• Projects at the intersection of biological/medical and IT technologies.